Love Island Star Becomes First Man to Speak Out About DES Health Impact
Former Love Island contestant Maxwell Samuda has become the first man to publicly discuss how a cancer-linked pregnancy drug taken by his grandmother over fifty years ago continues to affect his health today. The 26-year-old, who appeared on the ninth season of ITV's reality show, believes his reproductive system issues stem from exposure to diethylstilbestrol, commonly known as DES.
A Family's Multi-Generational Health Struggle
Samuda's grandmother, Maureen Day, 78, from Herne Bay in Kent, believes she took DES in 1972 and 1973. She initially took the synthetic estrogen during her second pregnancy to prevent miscarriage, then again after her premature son passed away to suppress breast milk production. Mrs. Day was diagnosed with breast cancer four years ago.
Samuda's mother, Natalie Samuda, 50, has faced her own health battles she attributes to DES exposure. The former midwife had pre-cancerous cells removed from her cervix at age 25, underwent fallopian tube removal due to fluid buildup, and had a complete hysterectomy last year. She also suffers from multiple autoimmune conditions that have significantly impacted her daily life for nearly a decade.
Samuda's Personal Health Journey
Maxwell Samuda required surgery as an infant for undescended testes, a condition where testicles fail to properly descend before birth. Five years ago, he discovered a benign lump on his scrotum and was diagnosed with varicocele, characterized by enlarged veins in the scrotum. Subsequent semen analysis revealed he has a low sperm count.
"Having a family is something that I'm really keen on doing one day, if I get the opportunity," Samuda told the Press Association. "Being told that you might potentially have issues with that - something I've always taken for granted in my head - I all of a sudden thought, 'oh, I'm not actually guaranteed that'... it's definitely an unsettling feeling."
The finance professional, who now lives in Dubai with his mother, maintains a healthy lifestyle without smoking or drinking but faces uncertainty about his reproductive future due to circumstances beyond his control.
The DES Legacy and Campaign for Justice
Diethylstilbestrol was prescribed to approximately 300,000 British women from the 1940s through the 1970s to prevent miscarriage, suppress breast milk production, and treat menopausal symptoms. The drug was linked to clear cell adenocarcinoma, a cancer of the cervix and vagina, in 1971, prompting U.S. regulators to advise against its use during pregnancy. However, DES continued to be prescribed in Europe until the late 1970s.
According to campaign group DES Justice UK (DJUK), the drug has caused infertility, reproductive abnormalities, and increased cancer risks across multiple generations. The organization, which now has over 500 members, met with Health Secretary Wes Streeting last month to push for a full public inquiry into what they describe as a "silent scandal."
"The story of Maureen, Natalie and Maxwell is a tragic but all too familiar one which shows that this isn't a historic injustice, but one that is affecting lives today," said Clare Fletcher, partner at Broudie Jackson Canter, which represents DJUK. "So many families have had their lives blighted and devastated because they trusted doctors and the government."
Calls for Action and Government Response
The Samuda family is backing DJUK's campaign for both a public inquiry and a compensation scheme similar to those established in the United States and Netherlands. Currently, the United Kingdom lacks any formal compensation program for DES victims.
Natalie Samuda emphasized the need for transparency: "Coming from a healthcare background myself, it needs a full inquiry to understand how, what, why and when, to ensure that this can't happen again. So many people's lives have been affected."
A Department of Health and Social Care spokesperson acknowledged the ongoing impact: "For too long, GPs and other health professionals have been unaware of the impacts of DES and support that should be offered to those exposed, despite so many women continuing to endure its devastating impacts a generation on."
The department noted that health minister Dr. Zubir Ahmed recently met with DES campaigners to discuss additional support measures, including enhanced clinical guidance and increased research into the drug's long-term, generational effects.
Breaking the Silence on Men's Health
Maxwell Samuda hopes his decision to speak publicly will encourage other men to address reproductive health concerns without shame or hesitation. "When it comes to men, sometimes it can be a habit of just keeping issues to yourself and overlooking certain things," he observed.
"The main thing that I would want men to take away from this situation is when there is something that you spot, get it looked at straight away. There's no reason to hide or to not feel comfortable about what it is that you're experiencing, especially when it can come to things like our reproductive system."
As the family continues their campaign for recognition and justice, they remain concerned about potential impacts on future generations. Mrs. Day expressed her distress: "For it to have affected Natalie and Maxwell is extremely upsetting. We also don't know if it will impact Maxwell's children if he is able to have them in the future."
